omeprazole has been researched along with Community Acquired Infection in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The AstraZeneca ARIADNE safety database was searched for comparative, controlled phase II-IV randomized, blinded clinical studies with esomeprazole and standard reporting of all adverse events (AEs)." | 1.35 | Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials. ( Estborn, L; Joelson, S, 2008) |
| "A prolonged GA inhibitor-induced hypochlorhydria has been suggested as a risk factor for severe gastrointestinal infections." | 1.33 | Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. ( Canani, RB; Cirillo, P; Guarino, A; Malamisura, B; Manguso, F; Morelli, L; Passariello, A; Roggero, P; Romano, C; Terrin, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estborn, L | 1 |
| Joelson, S | 1 |
| Farrell, S | 1 |
| Milliken, I | 1 |
| Doherty, GM | 1 |
| Murphy, JL | 1 |
| Wootton, SA | 1 |
| McCallion, WA | 1 |
| Canani, RB | 1 |
| Cirillo, P | 1 |
| Roggero, P | 1 |
| Romano, C | 1 |
| Malamisura, B | 1 |
| Terrin, G | 1 |
| Passariello, A | 1 |
| Manguso, F | 1 |
| Morelli, L | 1 |
| Guarino, A | 1 |
1 trial available for omeprazole and Community Acquired Infection
| Article | Year |
|---|---|
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired I | 2004 |
2 other studies available for omeprazole and Community Acquired Infection
| Article | Year |
|---|---|
Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Community-Acquired Infections; Esomeprazole; Female; Hum | 2008 |
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Topics: Achlorhydria; Acute Disease; Anti-Ulcer Agents; Child, Preschool; Community-Acquired Infections; Gas | 2006 |